DK148907C - Analogifremgangsmaade til fremstilling af dihydrocyclosporin c - Google Patents

Analogifremgangsmaade til fremstilling af dihydrocyclosporin c

Info

Publication number
DK148907C
DK148907C DK483176A DK483176A DK148907C DK 148907 C DK148907 C DK 148907C DK 483176 A DK483176 A DK 483176A DK 483176 A DK483176 A DK 483176A DK 148907 C DK148907 C DK 148907C
Authority
DK
Denmark
Prior art keywords
dihydrocyclosporin
preparation
analogy procedure
analogy
procedure
Prior art date
Application number
DK483176A
Other languages
English (en)
Other versions
DK483176A (da
DK148907B (da
Inventor
Artur Ruegger
Max Kuhn
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK483176A publication Critical patent/DK483176A/da
Priority to DK277085A priority Critical patent/DK277085D0/da
Publication of DK148907B publication Critical patent/DK148907B/da
Application granted granted Critical
Publication of DK148907C publication Critical patent/DK148907C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein
DK483176A 1975-11-04 1976-10-26 Analogifremgangsmaade til fremstilling af dihydrocyclosporin c DK148907C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK277085A DK277085D0 (da) 1975-11-04 1985-06-19 Mellemprodukt til anvendelse ved fremstilling af dihydrocyclosporin c

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1419575 1975-11-04
CH1419575A CH614931A5 (da) 1975-11-04 1975-11-04

Publications (3)

Publication Number Publication Date
DK483176A DK483176A (da) 1977-05-05
DK148907B DK148907B (da) 1985-11-11
DK148907C true DK148907C (da) 1986-04-07

Family

ID=4398730

Family Applications (1)

Application Number Title Priority Date Filing Date
DK483176A DK148907C (da) 1975-11-04 1976-10-26 Analogifremgangsmaade til fremstilling af dihydrocyclosporin c

Country Status (23)

Country Link
US (1) US4108985A (da)
JP (2) JPS5259180A (da)
AT (1) AT359642B (da)
AU (1) AU513538B2 (da)
BE (1) BE847941A (da)
CA (1) CA1087609A (da)
CH (2) CH614931A5 (da)
DE (2) DE2661031C2 (da)
DK (1) DK148907C (da)
ES (1) ES452942A1 (da)
FI (1) FI60701C (da)
FR (2) FR2330387A1 (da)
GB (2) GB1567201A (da)
IE (2) IE44749B1 (da)
IL (1) IL50836A (da)
NL (1) NL7612026A (da)
NO (1) NO763667L (da)
NZ (1) NZ182496A (da)
PH (1) PH14725A (da)
PT (1) PT65791B (da)
SE (2) SE432247B (da)
YU (1) YU270076A (da)
ZA (1) ZA766340B (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210581A (en) * 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
FR2410658A1 (fr) * 1977-11-30 1979-06-29 Science Union & Cie Nouveau produit biologique d'origine fongique, son obtention et son application a la therapeutique
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
US4201771A (en) * 1979-03-12 1980-05-06 Merck & Co., Inc. Antibiotic A43F
JPS5665853A (en) * 1979-11-01 1981-06-03 Sankyo Co Ltd Mycoplanesin derivative and its preparation
IE54936B1 (en) * 1980-02-14 1990-03-28 Sandoz Ltd A method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
US4396542A (en) * 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
US4370266A (en) * 1980-04-07 1983-01-25 Sankyo Company, Limited Mycoplanecin derivatives and their preparation
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8422253D0 (en) * 1984-09-04 1984-10-10 Sandoz Ltd Organic compounds
DE3587342T2 (de) * 1984-10-04 1993-12-02 Sandoz Ag Cyclosporine.
US4727035A (en) * 1984-11-14 1988-02-23 Mahoney Walter C Immunoassay for cyclosporin
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
GB8717299D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Peptides
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
JPH0667850B2 (ja) * 1987-09-03 1994-08-31 ユニバーシティ オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド 眼科用サイクロスポリン組成物
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
US4943560A (en) * 1988-04-06 1990-07-24 Regents Of The University Of Minnesota Solvent system for chronic vascular infusion of hydrophobic drugs
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
AU660651B2 (en) * 1991-01-25 1995-07-06 Fujisawa Pharmaceutical Co., Ltd. Process for producing cyclosporin A and/or C
ES2065273B1 (es) * 1993-05-25 1995-09-16 Biogal Gyogyszergyar Procedimiento para la purificacion de ciclosporina a.
US5709797A (en) * 1996-06-05 1998-01-20 Poli Industria Chimica S.P.A. Method of isolating cyclosporins
WO1998033512A1 (en) 1997-01-30 1998-08-06 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin a
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (da) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
ES2256959T3 (es) 1997-10-08 2006-07-16 Isotechnika,Inc. Analogos de ciclosporina deuterados y no deuterados y su uso como agentes inmunomoduladores.
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
CA2335903C (fr) 1998-07-01 2009-11-10 Debiopharm S.A. Nouvelle cyclosporine ayant un profil d'activite ameliore
MXPA04003623A (es) * 2001-10-19 2004-12-02 Isotechnika Inc Nuevas formulaciones analogas de ciclosporina.
ATE332917T1 (de) 2001-10-19 2006-08-15 Isotechnika Inc Synthese von cyclosporin-analogen
US20060014677A1 (en) * 2004-07-19 2006-01-19 Isotechnika International Inc. Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
JP2008514702A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
EP1809656A4 (en) 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
EP1812037A4 (en) 2004-10-06 2009-11-11 Amr Technology Inc ALKYNES OF CYCLOSPORINE AND THEIR USEFUL AS PHARMACEUTICAL AGENTS
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
US11311477B2 (en) 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US20080206287A1 (en) * 2006-09-18 2008-08-28 Reed John C Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
WO2010088573A1 (en) * 2009-01-30 2010-08-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) * 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) * 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) * 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8623814B2 (en) * 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
CN103153330B (zh) 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
SG10201510236XA (en) 2010-12-15 2016-01-28 Ciclofilin Pharmaceuticals Corp Cyclosporine analogue molecules modified at amino acid 1 and 3
WO2012145427A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
JP2016538317A (ja) 2013-08-26 2016-12-08 エナンタ ファーマシューティカルズ インコーポレイテッド Ｃ型肝炎を防止または治療するための新規シクロスポリン類似体
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2455859C2 (de) 1973-12-06 1983-12-15 Sandoz-Patent-GmbH, 7850 Lörrach Das Antibiotikum Cyclosporin A (S 7481/F-1), seine Herstellung und Verwendung

Also Published As

Publication number Publication date
ES452942A1 (es) 1978-01-16
JPS5259180A (en) 1977-05-16
NO763667L (da) 1977-05-05
GB1567201A (en) 1980-05-14
SE7611906L (sv) 1977-05-05
GB1567202A (en) 1980-05-14
NZ182496A (en) 1981-12-15
CH614931A5 (da) 1979-12-28
ZA766340B (en) 1978-06-28
IE44750L (en) 1977-05-04
IL50836A (en) 1979-10-31
DE2648121A1 (de) 1977-05-12
PT65791B (fr) 1978-07-05
DE2661031C2 (da) 1988-05-05
IL50836A0 (en) 1977-01-31
IE44749B1 (en) 1982-03-24
DK483176A (da) 1977-05-05
FI60701C (fi) 1982-03-10
SE8202039L (sv) 1982-03-30
JPS6210240B2 (da) 1987-03-05
CA1087609A (en) 1980-10-14
US4108985A (en) 1978-08-22
IE44749L (en) 1977-05-04
DE2648121C2 (de) 1986-05-28
FR2330387B1 (da) 1980-03-14
SE432247B (sv) 1984-03-26
YU270076A (en) 1982-05-31
JPS6253520B2 (da) 1987-11-10
AT359642B (de) 1980-11-25
DK148907B (da) 1985-11-11
AU513538B2 (en) 1980-12-11
FR2330387A1 (fr) 1977-06-03
PT65791A (fr) 1976-12-01
FR2338251A1 (fr) 1977-08-12
FR2338251B1 (da) 1984-01-13
BE847941A (fr) 1977-05-03
PH14725A (en) 1981-11-13
ATA812276A (de) 1980-04-15
IE44750B1 (en) 1982-03-24
JPS6277399A (ja) 1987-04-09
NL7612026A (nl) 1977-05-06
FI763049A (da) 1977-05-05
CH619735A5 (da) 1980-10-15
AU1926276A (en) 1978-05-11
FI60701B (fi) 1981-11-30

Similar Documents

Publication Publication Date Title
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK149107C (da) Analogifremgangsmaade til fremstilling af quinazolonderivater
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK151013C (da) Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider
DK146205C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
DK593975A (da) Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK143757C (da) Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK484676A (da) Fremgangsmade til fremstilling af aroyl-phenyliden- eller aroyl-phenylnaphthalenforbindelser
DK142845C (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK401476A (da) Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK55476A (da) Fremgangsmade til fremstilling af dinitronaphthalener
DK238776A (da) Fremgangsmade til fremstilling af 3-brombenzaldehyd

Legal Events

Date Code Title Description
PBP Patent lapsed